(AVD) American Vanguard - Ratings and Ratios

American Vanguard Corporation (NYSE:AVD) is a specialty chemical company that develops, manufactures, and markets products for agricultural, commercial, and consumer applications. The company produces a wide range of chemicals, including insecticides, fungicides, herbicides, soil health solutions, plant nutrition products, molluscicides, growth regulators, soil fumigants, and biorationals. These products are formulated in liquid, powder, and granular forms and are used to protect crops, turf, ornamental plants, and human and animal health. The company also distributes end-use chemical and biological products for crop applications and serves the turf and ornamental markets.

AVD operates through a network of subsidiaries and distributes its products through various channels, including national distribution companies, buying groups, co-operatives, sales offices, sales force executives, sales agents, and wholly-owned distributors. This diversified distribution strategy allows the company to maintain a strong presence in both domestic and international markets. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California, with a focus on delivering innovative solutions to the agricultural and chemical industries.

Ticker Symbol: AVD Exchange: NYSE Type: common stock Country Origin: United States GICS Sub Industry: Fertilizers & Agricultural Chemicals

Average Volume 20d: 184633 Last Price: 4.55 SMA 20: 5.39 SMA 50: 5.18 SMA 200: 6.45 ATR: 0.27

Market Cap: 140.48M USD P/E: 0.00 P/E Forward: 15.08 P/B: 0.45 P/S: 0.25 RoE: -8.82

3-month forecast: Based on the technical and fundamental data, AVDs stock price may face downward pressure in the near term. The last price of $4.55 is below the SMA 20 ($5.39) and SMA 50 ($5.18), indicating bearish momentum. The SMA 200 ($6.45) further suggests that the stock is trading below its long-term average. However, the forward P/E of 15.08 indicates potential optimism about future earnings. The low P/S ratio of 0.25 suggests undervaluation relative to sales, but the negative RoE of -8.82 raises concerns about profitability. The ATR of 0.27 signals moderate volatility, with potential price fluctuations within a narrow range.